Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Drugs like PDEI may help hair disorders like AGA.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

Hhip-Cre effectively targets dermal papilla cells for gene manipulation in hair biology.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

JAK inhibitors show promise for treating skin diseases effectively and safely.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

JAK inhibitors may reduce depression in people with alopecia areata.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Upadacitinib may effectively treat alopecia areata without side effects.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

Deucravacitinib may effectively treat discoid lupus erythematosus.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

The mutant HR bmh protein affects hair follicle formation by failing to repress vitamin D receptor activity.

Abrocitinib may effectively treat stubborn alopecia universalis.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

PP405 may help hair growth by activating hair follicle stem cells.